The drugs’ active ingredient, glatiramer acetate, has been linked to more than 80 cases of anaphylaxis worldwide since ...

Teva Pharmaceutical’s Copaxone was approved by the FDA in 1996 to treat relapsing forms of MS, an autoimmune disorder that ...

The FDA has added a boxed warning, its most serious designation, to Copaxone and Glatopa due to the risk of anaphylaxis, a rare but serious allergic reaction. This severe reaction can occur at any ...

Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.

Robert F. Kennedy Jr., Trump’s pick to be health secretary, is keeping his financial stake in major vaccine litigation ...

NEW YORK - Tiziana Life Sciences Ltd. (NASDAQ:TLSA), a biotech firm focused on immunomodulation therapies with a market ...

Carl's away, so I've punched out a bite-sized Evening Wrap ASX 200 ticked higher and finished the week up 1.19% Wesfarmers ...

The U.S. Food and Drug Administration has issued a recall on a popular skin moisturizer that's available nationwide. Do you have this product?

The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from ...

A proposed Mississippi bill would let bounty hunters track undocumented migrants. The DeSoto County DA announced it this week. Here's what we know.

Researchers at the University of Kentucky are in on a clinical trial on the use of medical cannabis for late-stage dementia patients. As research continues, those involved say this would be a game ...

Get free access to Word, Excel, and PowerPoint using Microsoft 365 for the web (formerly Office).